Stéphane Hunot
Stéphane Hunot
Unknown affiliation
Verified email at
Cited by
Cited by
Neuroinflammation in Alzheimer's disease
MT Heneka, MJ Carson, J El Khoury, GE Landreth, F Brosseron, ...
The Lancet Neurology 14 (4), 388-405, 2015
Neuroinflammation in Parkinson's disease: a target for neuroprotection?
EC Hirsch, S Hunot
The Lancet Neurology 8 (4), 382-397, 2009
Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids
K Yamagata, KI Andreasson, WE Kaufmann, CA Barnes, PF Worley
Neuron 11 (2), 371-386, 1993
Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease
V Brochard, B Combadière, A Prigent, Y Laouar, A Perrin, V Beray-Berthat, ...
The Journal of clinical investigation 119 (1), 2008
Caspase-3: a vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease
A Hartmann, S Hunot, PP Michel, MP Muriel, S Vyas, BA Faucheux, ...
Proceedings of the National Academy of Sciences 97 (6), 2875-2880, 2000
Nuclear translocation of NF-κB is increased in dopaminergic neurons of patients with Parkinson disease
S Hunot, B Brugg, D Ricard, PP Michel, MP Muriel, M Ruberg, ...
Proceedings of the National Academy of Sciences 94 (14), 7531-7536, 1997
Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration
P Teismann, K Tieu, DK Choi, DC Wu, A Naini, S Hunot, M Vila, ...
Proceedings of the National Academy of Sciences 100 (9), 5473-5478, 2003
Nitric oxide synthase and neuronal vulnerability in Parkinson's disease
S Hunot, F Boissiere, B Faucheux, B Brugg, A Mouatt-Prigent, Y Agid, ...
Neuroscience 72 (2), 355-363, 1996
FcεRII/CD23 is expressed in Parkinson’s disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-α in glial cells
S Hunot, N Dugas, B Faucheux, A Hartmann, M Tardieu, P Debre, Y Agid, ...
Journal of Neuroscience 19 (9), 3440-3447, 1999
Neuroinflammatory processes in Parkinson's disease
S Hunot, EC Hirsch
Annals of Neurology: Official Journal of the American Neurological …, 2003
Neuroinflammation in Parkinson's disease
EC Hirsch, S Vyas, S Hunot
Parkinsonism & related disorders 18, S210-S212, 2012
The Role of dial Reaction and Inflammation in Parkinson's Disease
EC Hirsch, T Breidert, E Rousselet, S Hunot, A Hartmann, PP Michel
DOCUMENTATION PAGE 991, 214-228, 2003
JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson's disease
S Hunot, M Vila, P Teismann, RJ Davis, EC Hirsch, S Przedborski, ...
Proceedings of the National Academy of Sciences 101 (2), 665-670, 2004
Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease
J Salazar, N Mena, S Hunot, A Prigent, D Alvarez-Fischer, M Arredondo, ...
Proceedings of the National Academy of Sciences 105 (47), 18578-18583, 2008
Glial cells and inflammation in Parkinson's disease: a role in neurodegeneration?
EC Hirsch, S Hunot, P Damier, B Faucheux
Annals of neurology 44 (S1 1), S115-S120, 1998
Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson disease
C Karachi, D Grabli, FA Bernard, D Tandé, N Wattiez, H Belaid, E Bardinet, ...
The Journal of clinical investigation 120 (8), 2745-2754, 2010
Deficiency in caspase-9 or caspase-3 induces compensatory caspase activation
TS Zheng, S Hunot, K Kuida, T Momoi, A Srinivasan, DW Nicholson, ...
Nature medicine 6 (11), 1241-1247, 2000
Caspase knockouts: matters of life and death
TS Zheng, S Hunot, K Kuida, RA Flavell
Cell Death & Differentiation 6 (11), 1043-1053, 1999
Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations
B Dehay, M Bourdenx, P Gorry, S Przedborski, M Vila, S Hunot, ...
The Lancet Neurology 14 (8), 855-866, 2015
Understanding dopaminergic cell death pathways in Parkinson disease
PP Michel, EC Hirsch, S Hunot
Neuron 90 (4), 675-691, 2016
The system can't perform the operation now. Try again later.
Articles 1–20